Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:ADAP
Tag: NASDAQ:ADAP
Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) had its Buy rating reiterated...
ME Staff
-
November 7, 2019
0
ADAPTIMMUNE THERAPEUTICS PLC (NASDAQ:ADAP) Files An 8-K Other Events
ME Staff 8-k
-
July 25, 2019
0
ADAPTIMMUNE THERAPEUTICS PLC (NASDAQ:ADAP) Files An 8-K Other Events
ME Staff 8-k
-
July 22, 2019
0
ADAPTIMMUNE THERAPEUTICS PLC (NASDAQ:ADAP) Files An 8-K Other Events
ME Staff 8-k
-
July 18, 2019
0
ADAPTIMMUNE THERAPEUTICS PLC (NASDAQ:ADAP) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
June 27, 2019
0
ADAPTIMMUNE THERAPEUTICS PLC (NASDAQ:ADAP) Files An 8-K Other Events
ME Staff 8-k
-
April 2, 2019
0
ADAPTIMMUNE THERAPEUTICS PLC (NASDAQ:ADAP) Files An 8-K Results of Operations and...
ME Staff 8-k
-
February 27, 2019
0
ADAPTIMMUNE THERAPEUTICS PLC (NASDAQ:ADAP) Files An 8-K Results of Operations and...
ME Staff 8-k
-
February 27, 2019
0
ADAPTIMMUNE THERAPEUTICS PLC (NASDAQ:ADAP) Files An 8-K Other Events
ME Staff 8-k
-
January 7, 2019
0
Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) price target lowered to $12.00...
ME Staff
-
December 13, 2018
0
1
2
3
...
6
Page 1 of 6
